Assembly Biosciences (ASMB) Curent Deferred Tax Liability (2016 - 2019)
Historic Curent Deferred Tax Liability for Assembly Biosciences (ASMB) over the last 5 years, with Q1 2019 value amounting to $3.3 million.
- Assembly Biosciences' Curent Deferred Tax Liability rose 5226.13% to $3.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $3.3 million, marking a year-over-year increase of 5226.13%. This contributed to the annual value of $3.3 million for FY2018, which is 5224.72% up from last year.
- Latest data reveals that Assembly Biosciences reported Curent Deferred Tax Liability of $3.3 million as of Q1 2019, which was up 5226.13% from $3.3 million recorded in Q4 2018.
- In the past 5 years, Assembly Biosciences' Curent Deferred Tax Liability registered a high of $11.6 million during Q1 2015, and its lowest value of $2.1 million during Q3 2018.
- Over the past 5 years, Assembly Biosciences' median Curent Deferred Tax Liability value was $11.1 million (recorded in 2017), while the average stood at $8.3 million.
- Per our database at Business Quant, Assembly Biosciences' Curent Deferred Tax Liability crashed by 8113.5% in 2018 and then soared by 5226.13% in 2019.
- Quarter analysis of 5 years shows Assembly Biosciences' Curent Deferred Tax Liability stood at $11.6 million in 2015, then fell by 4.14% to $11.1 million in 2016, then crashed by 80.79% to $2.1 million in 2017, then skyrocketed by 52.25% to $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019.
- Its Curent Deferred Tax Liability stands at $3.3 million for Q1 2019, versus $3.3 million for Q4 2018 and $2.1 million for Q3 2018.